Arctium lappa (Burdock): Insights from ethnopharmacology potential, chemical constituents, clinical studies, pharmacological utility and nanomedicine - 13/01/23

Abstract |
Arctium lappa L. is a medicinal edible homologous plant, commonly known as burdock or bardana, which belongs to the Asteraceae family. It is widely distributed throughout Northern Asia, Europe, and North America and has been utilized for hundreds of years. The roots, fruits, seeds, and leaves of A. lappa have been extensively used in traditional Chinese Medicine (TCM). A. lappa has attracted a great deal of attention due to its possession of highly recognized bioactive metabolites with significant therapeutic potential. Numerous pharmacological effects have been demonstrated in vitro and in vivo by A. lappa and its bioactive metabolites, including antimicrobial, anti-obesity, antioxidant, anticancer, anti-inflammatory, anti-diabetic, anti-allergic, antiviral, gastroprotective, hepatoprotective, and neuroprotective activities. Additionally, A. lappa has demonstrated considerable clinical efficacies and valuable applications in nanomedicine. Collectively, this review covers the properties of A. lappa and its bioactive metabolites, ethnopharmacology aspects, pharmacological effects, clinical trials, and applications in the field of nanomedicine. Hence, a significant attention should be paid to clinical trials and industrial applications of this plant with particular emphasis, on drug discovery and nanotechnology.
Le texte complet de cet article est disponible en PDF.Graphical Abstract |
Highlights |
• | Since ancient times, A. lappa L. has highly impact in traditional medicine. |
• | lappa L has attracted a great attention due to its highly bioactive metabolites. |
• | lappa L. has demonstrated considerable several clinical efficacies. |
• | lappa L. constitutes have unique mechanism of action in nanomedical application. |
Abbreviations : Covid-19, TCM, EMA, DCMQA, DPPH, H2O2,, NMDA, JNK, ERK 1/2, MAPKs, AMPK), mTOR, miRNA, GSK-3β, AKT, ERK1/2, ABTS, Nrf2/HO-1, SREBP-1, IL-6, (IL-1β, TNF-α, NLRP3, ATPase, mROS, PI3K/AKT, NF-κB, COX-2, MAPK, AMPK, MDA, NO, SOD, GSH, NADPH, GSH-Px, AR, VEGF, EGF, NGF, FGF-β, PDGF-BB, GST-P), PNLs, GLP‐1, HOMA‐IR, UCP1, PGC1α, PPARγ, C/EBPα), SREBP-1, SCD-1, NPs, XRD, TEM, FTIR, SEM, XPS, AFM, UV, EDX, MHA, PG, scCO2, EtOH, AcOEt, LDH, MMP, ROS, OGD/R, MQA, CNQX, b.w., ASALP, AST, ALT, ALP, LPS, PNG, TNBS, DMEM, IκBα, DAI, DSS, MPO, PBS, PCV2, CHOL, TC, FBG, Homa-IR, HDL-C, LDL-C, PBG, HbA1c, GK, OGTT, IPGTT, SGPT, DMSO
Keywords : Arctium lappa L., Folk medicine, Bioactive constituents, Preclinical trials, Clinical trials, Nanomedicine
Plan
Vol 158
Article 114104- février 2023 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
